H. Lee Moffit Cancer center and research institute

Tampa, Florida 33612

1 studies enrolling now · 2 studies all time

What they study most

Head and Neck, Non-small Cell Lung Cancer, Squamous Cell Cancer

Studies at this site

• Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer — Recruiting now
• Cetuximab at Either 500 or 750 mg/m2 Every Other Week for Recurrent or Metastatic Head and Neck Squamous Cell Cancer — Completed